 |
 |
|
 |
|
Accession |
Disease |
Description |
Year |
Source |
RNA-Seq |
Count |
Biomarkers |
|
GSE13070 |
Insulin Resistence |
Human Insulin Resistance and Thiazolidinedione-Mediated Insulin Sensitization |
2008 |
Tissue |
N |
364 |
 |
|
E-MTAB-6134 |
Pancreatic Cancer |
mRNA profiling by array for pancreatic ductal adenocarcinoma for clinical application |
2017 |
Tissue |
N |
309 |
|
|
E-MTAB-6690 |
Pancreatic Cancer |
A microarray meta-dataset of pancreatic cancer |
2018 |
Tissue |
N |
178 |
|
|
GSE73338 |
Pancreatic Cancer |
Pancreatic endocrine tumours: expression profiling evidences a rold for AKT-mTOR pathway |
2015 |
Tissue |
N |
97 |
|
|
GSE28735 |
Pancreatic Cancer |
Microarray gene-expression profiles of 45 matching pairs of pancreatic tumor and adjacent non-tumor tissues from 45 patients with pancreatic ductal adenocarcinoma |
2011 |
Tissue |
N |
90 |
|
|
GSE15471 |
Pancreatic Cancer |
Whole-Tissue Gene Expression Study of Pancreatic Ductal Adenocarcinoma |
2009 |
Tissue |
N |
78 |
|
|
GSE16515 |
Pancreatic Cancer |
Expression data from Mayo Clinic Pancreatic Tumor and Normal samples |
2009 |
Tissue |
N |
52 |
|
|
GSE67738 |
Diabetes |
Salivary Transcriptomic Biomarkers for Insulin Resistance |
2015 |
Saliva |
N |
38 |
 |
|
GSE15932 |
Diabetes |
Blood biomarkers of pancreatic cancer associated diabetes identified by peripheral blood-based gene expression profiles |
2009 |
Blood |
N |
32 |
|
|
GSE32676 |
Pancreatic Cancer |
Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer [mRNA] |
2011 |
Tissue |
N |
32 |
|
|
GSE74560 |
Obesity |
Whole blood gene expression from overweight women supplemented with quercetin or placebo |
2015 |
Blood |
N |
29 |
|
|
GSE14245 |
Pancreatic Cancer |
Multiple Salivary Biomarkers for Early Detection of Pancreatic Cancer |
2008 |
Saliva |
N |
24 |
 |
|
GSE22780 |
Pancreatic Cancer |
Affymetrix Arrays Interrogated with Tumor/Normal Pancreatic Samples |
2010 |
Tissue |
N |
16 |
|
|
|
|
|
|
|
|
|